Back to Best of AC17 Session - Emerging Strategies for the Prevention and Treatment of Graft-Versus-Host Disease - On-Demand
Best of AC17 Session - Emerging Strategies for the Prevention and Treatment of Graft-Versus-Host Disease - On-Demand

Best of AC17 Session - Emerging Strategies for the Prevention and Treatment of Graft-Versus-Host Disease - On-Demand

This session will focus on updates in the prevention and treatment of GVHD. It will cover the rationale, clinical evidence, and outcomes of the most widely employed methods to prevent and treat GVHD as well as introduce novel approaches, including B- and T-cell targeted therapies, anticytokine therapy, and chemotaxis blockade.

 

Content Area: Patient Management & Therapeutics

Product Details

Session from HOPA 2017 Annual Conference

Emerging Strategies for the Prevention and Treatment of Graft-Versus-Host Disease

Speaker: Alex Ganetsky, PharmD BCOP

Learning Objectives:

1.      Review the epidemiology, risk factors, and clinical manifestations of acute and chronic graft-versus-host disease (GVHD).

2.      Elucidate the most common approaches to prevention and treatment of GVHD.

3.      Discuss emerging strategies for the prevention and treatment of GVHD.

 

  • List Price: $35.00 USD
  • Member Price: $25.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $10.00 USD or more!
Become a member